Darryl Brundle and Ashley Kanter look at the contrasting pressures and easements on longevity associated with the pandemic
While the CMI Model of longevity improvements has proved reliable, Covid-19 threatens to cause it to show an unrealistic falls in life expectancy. Tim Gordon explains why the industry should not overreact
Just a fraction of liability growth since the start of the year will be offset by the impact of excess deaths caused by Covid-19, says Lane Clark & Peacock (LCP).
A scheme vulnerability analysis tool aiming to allow pension schemes to understand the likely impact of Covid-19 on their members’ life expectancy has been launched by XPS Pensions Group.
Nikhil Patel looks at how schemes have hedged longevity over the last decade, and how this will develop in the future.
Pension schemes and life insurers should be prepared for a modest change to their assumptions for mortality rates in the post-Covid-19 world, an academic study suggests.
After a bumper year, insurers are now facing a slower and smaller pipeline as schemes grapple with Covid-19, writes James Phillips.
The number of deaths registered in the UK in the week ending Friday 10 April (week 15) was 77% higher than expected if using the same standardised mortality rates as 2019, says the Continuous Mortality Investigation (CMI).
Very few schemes have protection in place against longevity risk in their scheme liabilities. Howard Kearns explains why and how to rectify this
Three Lloyds Banking Group pension schemes have transferred £10bn of longevity risk to Pacific Life Re in the second-largest longevity swap ever.